ARWR: Receives EU Approval
Arrowhead Pharmaceuticals receives European Commission marketing authorization for REDEMPLO to lower triglyceride levels in adult patients with familial chylomicronemia syndrome
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.